{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:14:48Z","timestamp":1758046488202,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.pharma.2021.03.004","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T11:59:27Z","timestamp":1616846367000},"page":"89-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["S\u00e9curit\u00e9 d\u2019approvisionnement\u00a0: mieux conna\u00eetre l\u2019organisation des fournisseurs"],"prefix":"10.1016","volume":"80","author":[{"given":"H.","family":"Vergne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Loubi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lawruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Poisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Paubel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2021.03.004_bib0140","unstructured":"ANSM. Bilan d\u2019activit\u00e9 2019 [Internet]. [cit\u00e9 18\u00a0janv 2021]. Disponible sur: https:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/6c30be5af41dfb185e078d230f294be9.pdf."},{"key":"10.1016\/j.pharma.2021.03.004_bib0145","unstructured":"ANSM. Bilan d\u2019activit\u00e9 2018 [Internet]. [cit\u00e9 5\u00a0mai 2020]. Disponible sur: https:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/1e7d5025d0ceefcf17a2be10892402a9.pdf."},{"key":"10.1016\/j.pharma.2021.03.004_bib0150","unstructured":"ANSM. Bilan d\u2019activit\u00e9 2013 [Internet]. [cit\u00e9 18\u00a0janv 2021]. Disponible sur: https:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/93113fec6d5c14e0ff12c88bf77aba23.pdf."},{"key":"10.1016\/j.pharma.2021.03.004_bib0155","unstructured":"The French Reporting System for Drug Shortages: Description and Trends From 2012\u00a0to 2018: An Observational Retrospective Study - PubMed [Internet]. [cit\u00e9 20\u00a0mai 2020]. Disponible sur: https:\/\/pubmed.ncbi.nlm.nih.gov\/32139487\/."},{"key":"10.1016\/j.pharma.2021.03.004_bib0160","unstructured":"Code de la sant\u00e9 publique - Article L5111-4."},{"key":"10.1016\/j.pharma.2021.03.004_bib0165","unstructured":"Arr\u00eat\u00e9 du 27\u00a0juillet 2016\u00a0fixant la liste des classes th\u00e9rapeutiques contenant des m\u00e9dicaments d\u2019int\u00e9r\u00eat th\u00e9rapeutique majeur mentionn\u00e9s \u00e0 l\u2019article L. 5121-31\u00a0du code de la sant\u00e9 publique. JORF no0178\u00a0du 2\u00a0ao\u00fbt 2016."},{"key":"10.1016\/j.pharma.2021.03.004_bib0170","unstructured":"Code de la sant\u00e9 publique - Article R5124-49-4."},{"year":"2019","series-title":"P\u00e9nurie de m\u00e9dicaments: le plan d\u2019actions du Leem. [Internet]. [atelier presse]","author":"Leem.","key":"10.1016\/j.pharma.2021.03.004_bib0175"},{"key":"10.1016\/j.pharma.2021.03.004_bib0180","unstructured":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9. Lutter contre les p\u00e9nuries et am\u00e9liorer la disponibilit\u00e9 des m\u00e9dicaments en France - Feuille de route 2019-2022 [Internet]. Disponible sur: https:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/31142_dicom_pe_nurie_de_me_dicamentsv8.pdf."},{"year":"2018","series-title":"Rapport de la mission d\u2019information sur les p\u00e9nuries de m\u00e9dicaments et de vaccins: les propositions cl\u00e9s [Internet]","author":"S\u00e9nat","key":"10.1016\/j.pharma.2021.03.004_bib0185"},{"year":"2018","series-title":"Rapport de l\u2019Acad\u00e9mie Nationale de Pharmacie \u00ab\u00a0Indisponibilit\u00e9 des m\u00e9dicaments\u00a0\u00bb [Internet]","author":"Acad\u00e9mie Nationale de Pharmacie","key":"10.1016\/j.pharma.2021.03.004_bib0190"},{"key":"10.1016\/j.pharma.2021.03.004_bib0195","article-title":"\u00ab\u00a0M\u00e9dicaments: Ruptures de stocks, ruptures d\u2019approvisionnement\u00a0\u00bb. Une probl\u00e9matique polymorphe, diversit\u00e9 d\u2019origines, solutions plurielles","author":"Acad\u00e9mie Nationale de Pharmacie","year":"2013","journal-title":"Recommandations [Internet]"},{"key":"10.1016\/j.pharma.2021.03.004_bib0200","unstructured":"S\u00e9nat. P\u00e9nuries de m\u00e9dicaments et de vaccins: renforcer l\u2019\u00e9thique de sant\u00e9 publique dans la cha\u00eene du m\u00e9dicament [Internet]. [cit\u00e9 6\u00a0mai 2020]. Disponible sur: http:\/\/www.senat.fr\/rap\/r17-737\/r17-737.html."},{"journal-title":"RFI","article-title":"Coronavirus: \u00ab\u00a0Le risque de rupture de stocks de m\u00e9dicaments est r\u00e9el\u00a0\u00bb [Internet]","year":"2020","key":"10.1016\/j.pharma.2021.03.004_bib0205"},{"key":"10.1016\/j.pharma.2021.03.004_bib0210","unstructured":"RMC. Production de m\u00e9dicaments\u00a0: faut-il relocaliser en France? [Internet]. RMC. RMC; [cit\u00e9 9\u00a0juin 2020]. Disponible sur\u00a0: https:\/\/rmc.bfmtv.com\/emission\/production-de-medicaments-faut-il-relocaliser-en-france-1894668.html."},{"year":"2020","series-title":"Coronavirus\u00a0: des impacts \u00e0 ne pas n\u00e9gliger. Communiqu\u00e9 de presse [Internet]","author":"Acad\u00e9mie Nationale de Pharmacie","key":"10.1016\/j.pharma.2021.03.004_bib0215"},{"year":"2020","series-title":"P\u00e9nuries des m\u00e9dicaments\u00a0: devant les comportements d\u00e9l\u00e9t\u00e8res des laboratoires, les pouvoirs publics doivent sortir de leur complaisance [Internet]","author":"UFC-Que Choisir","key":"10.1016\/j.pharma.2021.03.004_bib0220"},{"year":"2020","series-title":"Production du m\u00e9dicament\u00a0: comment retrouver une autonomie strat\u00e9gique? Les 10\u00a0propositions du Leem pour relancerla comp\u00e9titivit\u00e9 et l\u2019attractivit\u00e9 de la production de m\u00e9dicaments en France [Internet]","author":"Leem.","key":"10.1016\/j.pharma.2021.03.004_bib0225"},{"year":"2018","series-title":"Un CSIS de rupture pour restaurer l\u2019attractivit\u00e9 de la France [Internet]","author":"Leem.","key":"10.1016\/j.pharma.2021.03.004_bib0230"},{"year":"2018","series-title":"Discours de M. \u00c9douard Philippe, Premier ministre - Conseil Strat\u00e9gique des Industries de Sant\u00e9 [Internet]","key":"10.1016\/j.pharma.2021.03.004_bib0235"},{"year":"2019","series-title":"Contrat de fili\u00e8re des Industries et Technologies de Sant\u00e9 - Dossier de presse [Internet]","key":"10.1016\/j.pharma.2021.03.004_bib0240"},{"year":"2020","series-title":"France relance [Internet]","key":"10.1016\/j.pharma.2021.03.004_bib0245"},{"key":"10.1016\/j.pharma.2021.03.004_bib0250","unstructured":"Loi no 2019-1446\u00a0du 24\u00a0d\u00e9cembre 2019\u00a0de financement de la s\u00e9curit\u00e9 sociale pour 2020 - Article 48. JORF no0300\u00a0du 27\u00a0d\u00e9cembre 2019."},{"year":"2019","series-title":"Guidance on detection and notification of shortages of medicinal products for Marketing Authorisation Holders (MAHs) in the Union (EEA) [Internet]","author":"EMA.","key":"10.1016\/j.pharma.2021.03.004_bib0255"},{"year":"2020","series-title":"Rapport au Premier Ministre. Mission strat\u00e9gique visant \u00e0 r\u00e9duite les p\u00e9nuries de m\u00e9dicaments essentiels [Internet]","author":"Biot","key":"10.1016\/j.pharma.2021.03.004_bib0260"},{"year":"2019","series-title":"La base de donn\u00e9es des bonnes pratiques ARMEN [Internet]","author":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","key":"10.1016\/j.pharma.2021.03.004_bib0265"},{"year":"2019","series-title":"ARMEN vague 6 [Internet]","author":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","key":"10.1016\/j.pharma.2021.03.004_bib0135"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450921000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450921000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:35:12Z","timestamp":1757720112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450921000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0003450921000456"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2021.03.004","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00e9curit\u00e9 d\u2019approvisionnement\u00a0: mieux conna\u00eetre l\u2019organisation des fournisseurs","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2021.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}